$MRNA MODERNA BIG PUSH TODAY WITH MELANOMA Today announced that three abstracts on intismeran autogene, an investigational mRNA-based individualized neoantigen

$MRNA MODERNA BIG PUSH TODAY WITH MELANOMA Today announced that three abstracts on intismeran autogene, an investigational mRNA-based individualized neoantigen therapy, have been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026, which will be held October …